Infectious Diseases Multiplex Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Roche Molecular Systems, San Clemente, California.
Infectious Diseases Multiplex Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
J Mol Diagn. 2023 Dec;25(12):857-875. doi: 10.1016/j.jmoldx.2023.08.005. Epub 2023 Sep 26.
The use of clinical molecular diagnostic methods for detecting microbial pathogens continues to expand and, in some cases, supplant conventional identification methods in various scenarios. Analytical and clinical benefits of multiplex molecular panels for the detection of respiratory pathogens have been demonstrated in various studies. The use of these panels in managing different patient populations has been incorporated into clinical guidance documents. The Association for Molecular Pathology's Infectious Diseases Multiplex Working Group conducted a review of the current benefits and challenges to using multiplex PCR for the detection of pathogens from gastrointestinal tract, central nervous system, lower respiratory tract, and joint specimens. The Working Group also discusses future directions and novel approaches to detection of pathogens in alternate specimen types, and outlines challenges associated with implementation of these multiplex PCR panels.
临床分子诊断方法在检测微生物病原体方面的应用不断扩大,在某些情况下,已经取代了各种情况下的传统鉴定方法。多项分子检测板在呼吸道病原体检测方面的分析和临床优势已在多项研究中得到证实。这些检测板在管理不同患者人群方面已被纳入临床指导文件。分子病理学协会传染病多重检测工作小组对目前使用多重 PCR 检测胃肠道、中枢神经系统、下呼吸道和关节标本中病原体的优势和挑战进行了回顾。该工作组还讨论了检测其他类型标本中病原体的未来方向和新方法,并概述了实施这些多重 PCR 检测板所面临的挑战。